Nanoveu (ASX:NVU) Hits Silicon Milestone,16nm Chip Ready for TSMC Tape-Out
Nanoveu’s 16nm Chip Enters the Final Stretch. Nanoveu (ASX: NVU) has made solid technical progress with its subsidiary EMASS completing…
Metal Powder Works (ASX:MPW) Surges 12% on Austal Deal For US Shipbuilding
Austal Alliance Ignites 12% Jump for MPW as US Defence Looks Local. Metal Powder Works (ASX: MPW) shares rose 12%…
How Will The Bitcoin Recovery Unfold?
Another crypto crash has hit the cryptocurrency ecosystem. This time, it’s a big one. Bitcoin has fallen almost 30% in…
Brambles (ASX: BXB): Withstanding The Impacts of Trump’s Tariffs (For Now)
Brambles (ASX: BXB) has significantly outperformed the ASX 200 in the past year, gaining nearly 20% even with the drop…
‘Never buy an airline’: Who said this and does it still hold in the post-COVID-19 travel boom?
Never buy an airline – you’ve probably heard this saying before. Just why is this said and is it still…
Telix Pharmaceuticals (ASX:TLX) Down 55% Amid Lawsuit: Is It Time to Buy or Sell?
Telix Pharmaceuticals (ASX: TLX) has been crushed in 2025. The stock has fallen roughly 55% from its February high of…
Star Entertainment (ASX:SGR) Loses Another CEO: Is This Casino Stock Worth the Gamble?
Star Entertainment CEO Steps Down: What Next for SGR? Star Entertainment (ASX: SGR) shares rose 9.52% to close at A$0.12…
Karoon Energy (ASX:KAR) Drops to 6x P/E: Time to Buy the Dip?
Karoon Energy trades on 6x earnings as oil sentiment turns sour Karoon Energy (ASX: KAR) fell alongside the broader ASX…
Recce Pharmaceuticals (ASX: RCE) Secures A$85M R&D Backing: Is It a Buy Before Phase 3 Results?
Recce secures A$85m R&D backing as Phase 3 nears Recce Pharmaceuticals (ASX: RCE) hit a one-week high after landing an…
Will Weebit Nano (ASX:WBT) Deliver on Its Foundry Ambitions Before 2026?
Weebit Nano’s Year-End Challenge Weebit Nano (ASX: WBT) has now crossed an important threshold by moving into commercial revenue, but…
After a 20% Slide, Is Life360 (ASX:360) Now a Hidden Growth Opportunity?
Life360’s 20% Drop Raises the Question, Time to Buy or Stay Away? Life360 (ASX: 360) has been one of the…
DroneShield Bags $50M Deal as Repeat Buyers Fuel Its Flight Path
DroneShield’s $50M Contract Sends a Clear Signal DroneShield (ASX: DRO) announced this morning that it has secured a very large…
Drilling results from ASX explorers can send them surging or plunging! So here are 4 key things investors need to look for
Drilling results from ASX explorers are seen on the Market Announcements platform each day. Why do some results cause some…
Challenger (ASX:CGF): Apollo’s sell out was their loss but other investors’ gain!
When we last wrote about Challenger (ASX:CGF), in September 2024, investors were panicking because Apollo (a global fund manager that…
Cynata Therapeutics Completes Phase 2 Enrollment- Buy Before June or Wait for the Data?
Cynata Therapeutics (ASX: CYP) has completed patient enrollment in its Phase 2 clinical trial of a stem cell treatment called…